Long Term Clinical Implications in Chinese Patients With Aortic Intramural Hematoma

NCT03424785 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2018-02-07

No results posted yet for this study

Summary

The study evaluates outcomes of intramural hematomas after long-term follow up and establish predictive factors in Chinese population.

Conditions

  • Aortic Intramural Hematoma

Interventions

OTHER

drug, stent, surgical treatment

drug, stent, surgical treatment

Sponsors & Collaborators

  • Shenyang Northern Hospital

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
87 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-03
Primary Completion
2017-05-14
Completion
2017-05-14

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03424785 on ClinicalTrials.gov